Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)

International Journal of Cardiology

Volumn 158, Issue 1, 2012, Pages 6-11

  Golda, Adam ^a   Jurecka, Agnieszka ^b,c   Tylki Szymanska, Anna ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

Cardiac aneurysm; Cardiomyopathy; Heart failure; Maroteaux Lamy syndrome; Mucopolysaccharidosis type VI; Valvular disease

Indexed keywords

AZATHIOPRINE; CAPTOPRIL; DIGOXIN; DIURETIC AGENT; GLYCOSAMINOGLYCAN; N ACETYLGALACTOSAMINE 4 SULFATASE; PREDNISONE; VASODILATOR AGENT;

ACUTE HEART FAILURE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; BIOACCUMULATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPLETE HEART BLOCK; CORNEA OPACITY; CORONARY ARTERY DISEASE; DYSOSTOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOCARDIAL FIBROELASTOSIS; ENZYME REPLACEMENT; FACE MALFORMATION; HEART LEFT VENTRICLE ANEURYSM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HUMAN; JOINT STIFFNESS; MAROTEAUX LAMY SYNDROME; MYOCARDITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; HUMANS; MUCOPOLYSACCHARIDOSIS VI;

EID: 84861998734     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.097     Document Type: Review

References (44)

1. F. Baehner, C. Schmiedeskamp, and F. Krummenauer Cumulative incidence rates of the mucopolysaccharidoses in Germany J Inherit Metab Dis 28 2005 1011 1017
2. G. Malm, A.M. Lund, J.E. Mansson, and A. Heiberg Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence Acta Paediatr 97 2008 1577 1581
3. E.F. Neufeld, and J. Muenzer The mucopolysaccharidoses C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The metabolic and molecular bases of inherited diseases 7th edn. 2001 McGray-Hill New York 2465 2494
4. V. Valayannopoulos, H. Nicely, P. Harmatz, and S. Turbeville Mucopolysaccharidosis VI Orphanet J Rare Dis 12 2010 5:5
5. C.F. Wippermann, M. Beck, D. Schranz, R. Huth, I. Michel-Behnke, and B.K. Jungst Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses Eur J Pediatr 154 1995 98 101
6. C.S. Wilson, H.T. Mankin, and J.R. Pluth Aortic stenosis and mucopolysaccharidosis Ann Intern Med 92 1980 496 498
7. J.H. Dangel Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders - clinical and echocardiographic findings in 64 patients Eur J Pediatr 157 1998 534 538
8. A.C. Azevedo, I.V. Schwartz, and L. Kalakun Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI Clin Genet 66 2004 208 213
9. M.R. Chen, S.P. Lin, H.K. Hwang, and C.H. Yu Cardiovascular changes in mucopolysaccharidoses in Taiwan Acta Cardiol 60 2005 51 53
10. S.J. Swiedler, M. Beck, and M. Bajbouj Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) Am J MedGenet 134A 2005 144 150
11. L.V. Fong, S. Menahem, J.E. Wraith, and C.W. Chow Endocardial fibroelastosis in mucopolysaccharidosis type VI Clin Cardiol 10 1987 362 364
12. S. Hayflick, S. Rowe, A. Kavanaugh-McHugh, J.L. Olson, and D. Valle Acute infantile cardiomyopathy as a presenting feature of mucopolysaccharidosis VI J Pediatr 120 1992 269 272
13. A. Hinek, and S.E. Wilson Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly Am J Pathol 156 2000 925 938
14. A. Hinek, R.P. Mecham, F. Keeley, and M. Rabinovitch Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate J Clin Invest 88 1991 2083 2094
15. A. Hinek, S. Zhang, A.C. Smith, and J.W. Callahan Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase Am J Hum Genet 2000 23 36
16. A. Hinek, K.R. Braun, K. Liu, Y. Wang, and T.N. Wight Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients Am J Pathol 164 2004 119 131
17. J.-Y. Hwang, P. Johnson, and K.R. Braun Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury Am J Pathol 173 2008 1919 1928
18. M.J. Merrilees, J.M. Lemire, and J.W. Fischer Retrovirally mediated overexpression of versican of byarterial smooth muscle cells induces tropoelastin synthesis and elasticfiber formation in vitro and in neointima after vascular injury Circ Res 90 2002 481 487
19. S. Robins, V. Kumar, and R. Cotran Genetical disorders S. Robins, V. Kumar, R. Cotran, Pathologic Basis of Disease 4th edn 1989 W.B. Saunders Company Philadelphia 149 151
20. D. Rigante, and G. Segni Cardiac structural involvement in mucopolysaccharidoses Cardiology 98 2002 18 20
21. C.T. Tan, H.V. Schaff, F.A. Miller Jr., W.D. Edwards, and P.S. Karnes Valvular heart disease in four patients with Maroteaux-Lamy syndrome Circulation 85 1992 188 195
22. T.H. Marwick, B. Bastian, C.F. Hughes, and B.P. Bailey Mitral stenosis in the Maroteaux-Lamy syndrome: a treatable cause of dyspnoea Postgrad Med J 68 1992 287 288
23. G.Y. Oudit, J. Butany, W.G. Williams, S.C. Siu, J.T. Clarke, and R.M. Iwanochko Left ventricular aneurysm in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): clinical and pathological correlation Cardiovasc Pathol 16 2007 237 240
24. J. Nelson, M.D. Shields, and H.C. Mulholland Cardiovascular studies in the mucopolysaccharidoses J Med Genet 27 1990 94 100
25. R.M. Schieken, R.E. Kerber, V.V. Ionasescu, and H. Zellweger Cardiac manifestations of the mucopolysaccharidoses Circulation 52 1975 700 705
26. E. Dilber, A. Celiker, T. Karagöz, and H.S. Kalkanoǧlu Permanent transfemoral pacemaker implantation in a child with Maroteaux-Lamy syndrome Pacing Clin Electrophysiol 25 2002 1784 1785
27. V. Fesslová, P. Corti, and G. Sersale The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses Cardiol Young 19 2009 170 178
28. G.N. Leal, A.C. de Paula, C. Leone, and C.A. Kim Echocardiographic study of paediatric patients with mucopolysaccharidosis Cardiol Young 20 2010 254 261
29. P. Betremieux, C. Lefrançois, M.N. Guerin, C. Almange, B. Le Marec, and J. Senecal Acute cardiac insufficiency in a young girl with Maroteaux-Lamy disease. Favorable outcome under treatment Ann Pediatr (Paris) 32 7 1985 639 641
30. C. Keller, J. Briner, J. Schneider, M. Spycher, S. Rampini, and R. Gitzelmann Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient Helv Paediatr Acta 42 1987 317 333 German
31. G. Miller, and A. Partridge Mucopolysaccharidosis type VI presenting in infancy with endocardial fibroelastosis and heart failure Pediatr Cardiol 4 1983 61 62
32. www.americanheart.org - cardiovascular disease statistics
33. www.census.gov - Annual Estimates of the Population for the United States, Regions, States, and for Puerto Rico: April 1, 2000 to July 1, 2006 (NST-EST2006-01)
34. S.E. Leighton, B. Papsin, and A. Vellodi Disordered breathing during sleep in patients with mucopolysaccharidoses Int J Pediatr Otorhinolaryngol 58 2001 127 138
35. F.H. Kuniyoshi, S. Pusalavidyasagar, P. Singh, and V.K. Somers Cardiovascular consequences of obstructive sleep apnoea Indian J Med Res 131 2010 196 205
36. N. Galiè, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
37. M.H. Ellestad, R. Gaso, and P.S. Greenber Permanent pacemaker implantation using the femoral vein: a preliminary report PACE 3 1980 418 423
38. S. Villalba, J. Rodal, and J. Todoli The femoral vein route: an exceptional alternative for the implantation of permanent pacemaker Rev Esp Cardiol 47 1994 490 492
39. K. Barakat, J. Hill, and P. Kelly Permanent transfemoral pacemaker implantation is the technique of choice for patients in whom the superior vena cava is incredible PACE 23 2000 446 449
40. M.D. Tarantino, A. Lail, and S.M. Donfield Surveillance of infectious complications associated with central venous access devices in children with haemophilia Haemophilia 9 2003 588 592
41. R. Giugliani, P. Harmatz, and J.E. Wraith Management guidelines for mucopolysaccharidosis VI Pediatrics 120 2007 405 418
42. E. Herskhovitz, E. Young, and J. Rainer Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up J Inherit Metab Dis 22 1999 50 62
43. Powdel JL, Hingorani P, Kolb EA. Pediatric Hemapoetic Stem Cell Transplantation eMedicine (emedicine.medscape.com, update Sep 11, 2009).
44. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2